Healthcare provider profile · identity verified

Rapha Wiley, MD

Hospitalist · OWASSO, OK · NPI 1932493178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	738	235
Lisinopril	Lisinopril	646	206
Levothyroxine Sodium	Levothyroxine Sodium	557	145
Losartan Potassium	Losartan Potassium	442	146
Amlodipine Besylate	Amlodipine Besylate	433	150
Omeprazole	Omeprazole	409	136
Rosuvastatin Calcium	Rosuvastatin Calcium	372	126
Gabapentin	Gabapentin	362	114
Pantoprazole Sodium	Pantoprazole Sodium	334	101
Metoprolol Succinate	Metoprolol Succinate	317	104
Hydrochlorothiazide	Hydrochlorothiazide	264	80
Tamsulosin Hcl	Tamsulosin Hcl	264	76
Carvedilol	Carvedilol	229	71
Eliquis	Apixaban	229	47
Metformin Hcl	Metformin Hcl	224	77
Simvastatin	Simvastatin	218	66
Montelukast Sodium	Montelukast Sodium	200	68
Potassium Chloride	Potassium Chloride	189	62
Furosemide	Furosemide	186	60
Trazodone Hcl	Trazodone Hcl	179	59
Pravastatin Sodium	Pravastatin Sodium	158	49
Citalopram Hbr	Citalopram Hydrobromide	145	43
Nifedipine Er	Nifedipine	138	39
Metoprolol Tartrate	Metoprolol Tartrate	135	41
Albuterol Sulfate Hfa	Albuterol Sulfate	133	61
Escitalopram Oxalate	Escitalopram Oxalate	131	51
Metformin Hcl Er	Metformin Hcl	127	37
Allopurinol	Allopurinol	120	36
Sertraline Hcl	Sertraline Hcl	120	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	31
Spironolactone	Spironolactone	117	39
Famotidine	Famotidine	114	38
Meloxicam	Meloxicam	113	33
Clopidogrel	Clopidogrel Bisulfate	108	40
Hydralazine Hcl	Hydralazine Hcl	105	37
Tramadol Hcl	Tramadol Hcl	105	17
Duloxetine Hcl	Duloxetine Hcl	104	28
Alendronate Sodium	Alendronate Sodium	101	30
Buspirone Hcl	Buspirone Hcl	99	36
Glimepiride	Glimepiride	89	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	31
Ozempic	Semaglutide	85	23
Ezetimibe	Ezetimibe	83	21
Pioglitazone Hcl	Pioglitazone Hcl	80	28
Warfarin Sodium	Warfarin Sodium	78	25
Amitriptyline Hcl	Amitriptyline Hcl	77	26
Jardiance	Empagliflozin	73	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	30
Quetiapine Fumarate	Quetiapine Fumarate	72	25
Tizanidine Hcl	Tizanidine Hcl	71	20
Fluticasone Propionate	Fluticasone Propionate	68	29
Glipizide Er	Glipizide	66	22
Fluoxetine Hcl	Fluoxetine Hcl	65	22
Clonidine Hcl	Clonidine Hcl	62	20
Mounjaro	Tirzepatide	62	17
Celecoxib	Celecoxib	60	21
Lovastatin	Lovastatin	60	17
Atenolol	Atenolol	58	20
Mirtazapine	Mirtazapine	58	14
Donepezil Hcl	Donepezil Hcl	57	15
Trulicity	Dulaglutide	57	14
Ropinirole Hcl	Ropinirole Hcl	56	15
Glipizide	Glipizide	55	18
Venlafaxine Hcl Er	Venlafaxine Hcl	55	15
Finasteride	Finasteride	54	18
Olmesartan Medoxomil	Olmesartan Medoxomil	54	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	26
Xarelto	Rivaroxaban	50	11
Chlorthalidone	Chlorthalidone	46	17
Pregabalin	Pregabalin	46	suppressed
Telmisartan	Telmisartan	46	13
Dicyclomine Hcl	Dicyclomine Hcl	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	13
Hydroxyzine Hcl	Hydroxyzine Hcl	40	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	14
Torsemide	Torsemide	39	13
Paroxetine Hcl	Paroxetine Hcl	38	14
Novolog Flexpen	Insulin Aspart	37	suppressed
Baclofen	Baclofen	36	16
Ipratropium Bromide	Ipratropium Bromide	35	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Cephalexin	Cephalexin	34	30
Colestipol Hcl	Colestipol Hcl	34	12
Estradiol	Estradiol	34	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	15
Sucralfate	Sucralfate	34	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	13
Propranolol Hcl	Propranolol Hcl	32	14
Synthroid	Levothyroxine Sodium	32	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Enalapril Maleate	Enalapril Maleate	31	11
Bupropion Xl	Bupropion Hcl	30	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Prednisone	Prednisone	30	23
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Valsartan	Valsartan	27	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Alprazolam	Alprazolam	25	12
Benazepril Hcl	Benazepril Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	19
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Cefdinir	Cefdinir	22	20
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Ondansetron Odt	Ondansetron	21	16
Topiramate	Topiramate	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluconazole	Fluconazole	19	18
Terazosin Hcl	Terazosin Hcl	19	suppressed
Azithromycin	Azithromycin	17	17
Levemir Flexpen	Insulin Detemir	17	suppressed
Ramipril	Ramipril	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Sulindac	Sulindac	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Linzess	Linaclotide	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Acarbose	Acarbose	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Glyburide	Glyburide	13	suppressed
Levofloxacin	Levofloxacin	13	12
Potassium Citrate Er	Potassium Citrate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Chlordiazepoxide-Amitriptyline	Amitriptyline/Chlordiazepoxide	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Clonidine	Clonidine	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Novolin R Flexpen	Insulin Regular, Human	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error